Dr. Michael Wong, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Toronto Faculty Of Medicine

  Medical School, 1989

• Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results, 2023-03-30

• Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature, 2019-06-24

• Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response, 2021-12-23

• Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis, 2018-10-11

• Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSMregistry, 2017-12-19

• Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma, 2022-10-17

• Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade, 2023-07-18

• B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density, 2019-02-26

• Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome, 2018-05-30

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two National Harbor, MD, USA. 9-13 November 2016, 2016-11-16

• Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma, 2022-05-02

• Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature, 2019-04-16

• Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2023-03-09

• Elective Neck Dissection Versus Observation in Patients With Head and Neck Cutaneous Squamous Cell Carcinoma, 2021-08-06

• Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2022-10-26

• Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis, 2019-04-17